Anavex Life Sciences Corp (AVXL)

[falconer66a]

No ‘magic.’ Just a powerful, unique MOA.

It [blarcamesine] will not be magically superior nor exclusive to any and all other experimental therapies.

Really? Tell us. What other new drugs or procedures do you see that might have pre-clinical evidence of superiority to blarcamesine? Or, any new non-pharmaceutical therapies or protocols?

You didn’t read (or understand) my posting; made no reference to ‘magic.’ Nothing paranormal about blarcamesine. But it does possess/involve a unique mechanism of action (MOA), at the sigma-1 receptor protein. With that protein’s consequent activation all sorts of “downstream” reaction pathways and sequences are facilitated, all of which, in collaboration, restore normalized neuron function.

In essence, it’s blarcamesine’s unique MOA that seals the therapeutic deal(s). No indications whatsoever that any other non-Anavex drug can match it, as to either safety nor efficacy.

You are right on one point. Blarcamesine will not be “exclusive.” Any and all pharmaceuticals are welcome to put forward their own new CNS drugs. No indication whatsoever that any of them will be able approach the safety and efficacies of blarcamesine. Patients and physicians may eventually have a larger number of approved CNS disease drugs to choose from. Right now, for Alzheimer’s there’s Aricept and aduhelm. Would you select either of those, over blarcamesine, for your grandmother’s Alzheimer’s (should she have that disease)?